Applied Gross Profit from 2010 to 2024

APLT Stock

USD 8.57 1.64 16.06%

Applied Therapeutics Gross Profit yearly trend continues to be comparatively stable with very little volatility. Gross Profit is likely to outpace its year average in 2024. Gross Profit is the profit Applied Therapeutics makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2010-12-31

Previous Quarter

9.6 M

Current Value

10.1 M

Quarterly Volatility

3.5 M

Credit Downgrade

Yuan Drop

Covid

Check Applied Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Applied Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 1.4 M, Interest Income of 1.1 M or Discontinued Operations of 0.0, as well as many indicators such as Price To Sales Ratio of 22.59, Dividend Yield of 0.0 or Days Sales Outstanding of 8.33. Applied financial statements analysis is a perfect complement when working with Applied Therapeutics Valuation or Volatility modules.

Check out the analysis of Applied Therapeutics Correlation against competitors.

For more information on how to buy Applied Stock please use our How to Invest in Applied Therapeutics guide.

Latest Applied Therapeutics' Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Applied Therapeutics over the last few years. Gross profit is a required income statement account that reflects total revenue of Applied Therapeutics minus its cost of goods sold. It is profit before Applied Therapeutics operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Applied Therapeutics' Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Applied Therapeutics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 0

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

Applied Gross Profit Regression Statistics

	Arithmetic Mean	1,233,533
	Geometric Mean	0.00
	Coefficient Of Variation	285.04
	Mean Deviation	2,305,991
	Median	0.00
	Standard Deviation	3,516,005
	Sample Variance	12.4T
	Range	10.6M
	R-Value	0.56
	Mean Square Error	9.1T
	R-Squared	0.32
	Significance	0.03
	Slope	441,582
	Total Sum of Squares	173.1T

Applied Gross Profit History

	2024	10.1 M
	2023	9.6 M
	2022	-441 K
	2021	-415 K
	2020	-380 K
	2019	-23 K

Other Fundumenentals of Applied Therapeutics

Gross Profit Margin

Applied Therapeutics Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Capital Surpluse	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Current Deferred Revenue	Net Receivables
Total Assets		0.75	0.89	-0.94	-0.66	0.52	0.86	0.56	0.76	1.0	0.7	0.61	-0.27
Total Stockholder Equity	0.75		0.42	-0.55	-0.03	0.51	0.35	-0.12	1.0	0.75	0.99	0.91	0.35
Net Tangible Assets	0.89	0.42		-0.88	-0.88	0.38	0.98	0.81	0.43	0.89	0.35	0.27	-0.63
Net Debt	-0.94	-0.55	-0.88		0.78	-0.37	-0.9	-0.73	-0.55	-0.94	-0.48	-0.45	0.4
Retained Earnings	-0.66	-0.03	-0.88	0.78		-0.3	-0.94	-0.96	-0.04	-0.67	0.05	0.12	0.86
Accounts Payable	0.52	0.51	0.38	-0.37	-0.3		0.4	0.14	0.51	0.52	0.46	0.22	-0.02
Capital Surpluse	0.86	0.35	0.98	-0.9	-0.94	0.4		0.86	0.35	0.86	0.27	0.18	-0.7
Total Liab	0.56	-0.12	0.81	-0.73	-0.96	0.14	0.86		-0.11	0.56	-0.2	-0.23	-0.84
Net Invested Capital	0.76	1.0	0.43	-0.55	-0.04	0.51	0.35	-0.11		0.76	0.99	0.91	0.34
Total Current Assets	1.0	0.75	0.89	-0.94	-0.67	0.52	0.86	0.56	0.76		0.69	0.61	-0.27
Net Working Capital	0.7	0.99	0.35	-0.48	0.05	0.46	0.27	-0.2	0.99	0.69		0.94	0.43
Current Deferred Revenue	0.61	0.91	0.27	-0.45	0.12	0.22	0.18	-0.23	0.91	0.61	0.94		0.52
Net Receivables	-0.27	0.35	-0.63	0.4	0.86	-0.02	-0.7	-0.84	0.34	-0.27	0.43	0.52

Click cells to compare fundamentals

About Applied Therapeutics Financial Statements

Applied Therapeutics shareholders use historical fundamental indicators, such as Gross Profit, to determine how well the company is positioned to perform in the future. Although Applied Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Applied Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Applied Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Gross Profit	9.6 M	10.1 M
Gross Profit Margin	0.87	0.77

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Applied Stock Analysis

When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC